CJC-1295 vs CJC-1295 DAC: What’s the Difference?
The main difference between CJC-1295 and CJC-1295 DAC is mechanism: CJC-1295 is studied for sustained ghrh stimulation research — Short-acting GHRH analog. CJC-1295 DAC is studied for long-acting ghrh analog research — GHRH analog with Drug Affinity Complex (DAC) attached.
Short-acting GHRH analog vs albumin-bound long-acting.
Key differences between CJC-1295 and CJC-1295 DAC
- •Mechanism: CJC-1295 — Short-acting GHRH analog. CJC-1295 DAC — GHRH analog with Drug Affinity Complex (DAC) attached.
- •Primary research focus: CJC-1295 is studied for sustained ghrh stimulation research; CJC-1295 DAC is studied for long-acting ghrh analog research.
- •Depth of human research: CJC-1295 — Moderate; CJC-1295 DAC — Moderate.
- •Typical study cadence cited in the literature: CJC-1295 — 2–3× daily — paired in same syringe with Ipamorelin; CJC-1295 DAC — 1–2× weekly.
| Attribute | CJC-1295 GHRH analog | CJC-1295 DAC CJC-1295 with Drug Affinity Complex |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | Sustained GHRH stimulation research | Long-acting GHRH analog research |
| Mechanism of action | Short-acting GHRH analog. Mimics natural pulsatile GH release. | GHRH analog with Drug Affinity Complex (DAC) attached. Half-life extends to ~8 days for sustained GH elevation. |
| Human research | Moderate | Moderate |
| Animal research | Moderate | Moderate |
| Mechanistic research | Established | Established |
| Study cadence cited | 2–3× daily — paired in same syringe with Ipamorelin | 1–2× weekly |
| In plain English | If ipamorelin opens the GH faucet, CJC-1295 widens the pipe. Together they produce larger natural GH pulses. | Same molecule as no-DAC CJC-1295, but it sticks to a carrier protein in the blood so it lasts much longer. |
| How it works | Activates the GHRH receptor in the pituitary, increasing the amplitude of natural GH pulses. | DAC-modified CJC-1295 binds albumin and continuously activates the pituitary GHRH receptor, producing a steady 'GH bleed' rather than discrete pulses. |
| Researchers study | GH secretion, IGF-1 levels, body composition, and sleep architecture. | Sustained IGF-1 elevation, recovery, and body-composition research. |
| Internet discussion | DAC vs no-DAC is the eternal forum debate. | Famous DAC vs no-DAC debate on every peptide forum. |
Mechanism and research evidence, side by side
How CJC-1295 and CJC-1295 DAC differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
CJC-1295
Short-acting GHRH analog. Mimics natural pulsatile GH release.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Mimics natural GH pulses; foundational stack with Ipamorelin
CJC-1295 DAC
GHRH analog with Drug Affinity Complex (DAC) attached. Half-life extends to ~8 days for sustained GH elevation.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Sustained GH elevation rather than pulses
CJC-1295
Sustained GHRH stimulation research
If ipamorelin opens the GH faucet, CJC-1295 widens the pipe. Together they produce larger natural GH pulses.
Activates the GHRH receptor in the pituitary, increasing the amplitude of natural GH pulses.
GH secretion, IGF-1 levels, body composition, and sleep architecture.
DAC vs no-DAC is the eternal forum debate.
CJC-1295 is a GHRH analog that amplifies natural GH pulses, especially when paired with a ghrelin mimetic.
CJC-1295 DAC
Long-acting GHRH analog research
Same molecule as no-DAC CJC-1295, but it sticks to a carrier protein in the blood so it lasts much longer.
DAC-modified CJC-1295 binds albumin and continuously activates the pituitary GHRH receptor, producing a steady 'GH bleed' rather than discrete pulses.
Sustained IGF-1 elevation, recovery, and body-composition research.
Famous DAC vs no-DAC debate on every peptide forum.
CJC-1295 DAC is the long-acting albumin-bound GHRH analog researched for sustained GH and IGF-1 elevation.